ProMIS Neurosciences Balance Sheet Health
Financial Health criteria checks 4/6
ProMIS Neurosciences has a total shareholder equity of $7.3M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $24.5M and $17.2M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$21.57m |
| Equity | US$7.27m |
| Total liabilities | US$17.24m |
| Total assets | US$24.51m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: PMN's short term assets ($24.5M) exceed its short term liabilities ($2.6M).
Long Term Liabilities: PMN's short term assets ($24.5M) exceed its long term liabilities ($14.6M).
Debt to Equity History and Analysis
Debt Level: PMN is debt free.
Reducing Debt: PMN had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: PMN has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: PMN has less than a year of cash runway if free cash flow continues to reduce at historical rates of 26.4% each year